MLPA® - MRC Holland Kits

Please note before download:

  • Mix descriptions are only free of charge for customers with maintenance contract.
  • Don't hesitate to contact us, if there are any mix descriptions missing on this website.
  • To set up a new mix descriptions for you, still available at MRC Hollands website, please provide us the name of the mix (e.g. P002-D1), the version of the mix (e.g. Vs.02) and the date of its release.

  • To set up a new mix descriptions for you, not available at MRC Hollands website any more, please provide us the corresponding document by email or fax (+49-7822-440150-20).

Download

  • log into your SEQUENCE PILOT installation
  • go to category MLPA®
  • go to operation Mixes [master file]
  • press button [Import] and select the downloaded mme-file
  • if the corresponding mix already exists in your SEQUENE_PILOT installation you will be asked "Do you want to save the mix with a new name / lot?"; please press button [Yes] and complete the fields in the following dialogue; press button [OK] to save your entries
  • if the mix doesn't exist yet just press button [OK] in the following dialogue
MIX
VERSION
DATE
REGION
APPLICATION
DOWNLOAD
MIX
P040-B1
VERSION
Vs. 10
DATE
12-08-2015
REGION
Various
APPLICATION
Chronic Lymphocytic Leukemia (CLL)
MIX
P040-B1
VERSION
Vs. 11
DATE
11-12-2015
REGION
Various
APPLICATION
Chronic Lymphocytic Leukemia (CLL)
MIX
P041-B1
VERSION
Vs. 12
DATE
03-11-2014
REGION
ATM 11q23
APPLICATION
Ataxia-Telangiectasia (AT)
MIX
P041-B1
VERSION
Vs. B1/B2-01
DATE
28-03-2017
REGION
ATM 11q23
APPLICATION
Ataxia-Telangiectasia (AT)
MIX
P042-B1
VERSION
Vs. 12
DATE
03-11-2014
REGION
ATM 11q23
APPLICATION
Ataxia-Telangiectasia (AT)
MIX
P042-B2
VERSION
Vs. B1/B2-01
DATE
28-03-2017
REGION
ATM 11q23
APPLICATION
Ataxia-Telangiectasia (AT)
MIX
P043-E1
VERSION
Vs. 30
DATE
19-06-2017
REGION
APC, 5q21-q22
APPLICATION
Hereditary Polyposis Colon Cancer
MIX
P043-E1
VERSION
Vs. E1-01
DATE
25-07-2017
REGION
APC, 5q21-q22
APPLICATION
Hereditary Polyposis Colon Cancer
MIX
P044-B2
VERSION
Vs. 15
DATE
12-08-2015
REGION
NF2 22q12
APPLICATION
Neurofibromatosis type 2 (NF2)
MIX
P044-B3
VERSION
Vs. 16
DATE
24-11-2016
REGION
NF2 22q12
APPLICATION
Neurofibromatosis type 2 (NF2)
MIX
P045-C1
VERSION
Vs. C1-02
DATE
08-06-2017
REGION
BRCA2 13q12.3, CHEK2 22q12.1
APPLICATION
Breast cancer, hereditary
MIX
P045-C1
VERSION
Vs. C1-03
DATE
26-09-2017
REGION
BRCA2 13q12.3, CHEK2 22q12.1
APPLICATION
Breast cancer, hereditary
MIX
P046-C1
VERSION
Vs. 12
DATE
26-11-2015
REGION
TSC2 16p13.3
APPLICATION
Tuberous Sclerosis
MIX
P046-C1
VERSION
Vs. 13
DATE
10-02-2017
REGION
TSC2 16p13.3
APPLICATION
Tuberous Sclerosis
MIX
P047-D1
VERSION
Vs. 19
DATE
02-12-2016
REGION
RB1 13q14
APPLICATION
Retinoblastoma (RB)
MIX
P047-E1
VERSION
Vs. 20
DATE
13-12-2017
REGION
RB1 13q14
APPLICATION
Retinoblastoma (RB)
MIX
P048-C1
VERSION
Vs. 17
DATE
01-07-2016
REGION
LMNA 1q21.2-1q21.3
APPLICATION
Laminopathies, Limb-girdle muscular dystrophy, Myofibrillar myopathies
MIX
P048-C2
VERSION
Vs. 18
DATE
21-02-2017
REGION
LMNA 1q21.2-1q21.3
APPLICATION
Laminopathies, Limb-girdle muscular dystrophy, Myofibrillar myopathies
MIX
P049-C2
VERSION
Vs. C2-01
DATE
30-04-2018
REGION
SLC6A8, Xq28
APPLICATION
Creatine transporter, x-linked
MIX
P049-C2
VERSION
Vs. C2-02
DATE
06-06-2018
REGION
SLC6A8, Xq28
APPLICATION
Creatine transporter, x-linked
MIX
P050-C1
VERSION
Vs. 35
DATE
16-08-2017
REGION
CYP21A2 6p21.3
APPLICATION
Congenital adrenal hyperplasia
MIX
P050-C1
VERSION
Vs. C1-01
DATE
17-05-2018
REGION
CYP21A2 6p21.3
APPLICATION
Congenital adrenal hyperplasia
MIX
P051-D1
VERSION
Vs. 27
DATE
16-01-2015
REGION
PARK2 6q25.2, SNCA 4q21, Pink1, Park7 1p36
APPLICATION
Parkinson disease, familial
MIX
P051-D2
VERSION
Vs. D2-01
DATE
03-08-2018
REGION
PARK2 6q25.2, SNCA 4q21, Pink1, Park7 1p36
APPLICATION
Parkinson disease, familial
MIX
P052-C2
VERSION
Vs. 26
DATE
25-07-2014
REGION
PARK2 6q25.2, SNCA 4q21, Pink1, Park7 1p36
APPLICATION
Parkinson disease, familial
MIX
P052-D1
VERSION
Vs. 27
DATE
16-01-2015
REGION
PARK2 6q25.2, SNCA 4q21, Pink1, Park7 1p36
APPLICATION
Parkinson disease, familial
MIX
P054-C1
VERSION
Vs.14
DATE
07-11-2014
REGION
FOXL2, TWIST1, FOXC1, FOXC2, ATR, PITX2, GPR143
APPLICATION
Ophthalmogenetic anomalies
MIX
P054-C2
VERSION
Vs.16
DATE
09-08-2017
REGION
FOXL2, TWIST1, FOXC1, FOXC2, ATR, PITX2, GPR143
APPLICATION
Ophthalmogenetic anomalies
MIX
P055-D1
VERSION
Vs. D1-01
DATE
18-01-2016
REGION
PAH 12q24.1
APPLICATION
Phenylketonuria
MIX
P055-D1
VERSION
Vs. D1-02
DATE
04-04-2017
REGION
PAH 12q24.1
APPLICATION
Phenylketonuria
MIX
P056-C1
VERSION
Vs. 16
DATE
23-04-2015
REGION
P53 17q13.1
APPLICATION
Li-Fraumeni syndrome (LFS)
MIX
P056-D1
VERSION
Vs. D1-01
DATE
27-06-2018
REGION
P53 17q13.1
APPLICATION
Li-Fraumeni syndrome (LFS)
MIX
P057-B1
VERSION
Vs. 17
DATE
21-12-2012
REGION
FANCD2. 3p25.3, PALB2 16p12
APPLICATION
Fanconi anemia (FA)
MIX
P057-B2
VERSION
Vs. 18
DATE
24-06-2015
REGION
FANCD2. 3p25.3, PALB2 16p12
APPLICATION
Fanconi anemia (FA)
MIX
P058-A2
VERSION
Vs. 08
DATE
21-12-2012
REGION
IGHMBP2 11q13
APPLICATION
Distal spinal muscular atrophy 1 (DSMA1), SMARD1, dHMN6
MIX
P058-A3
VERSION
Vs. 10
DATE
17-11-2016
REGION
IGHMBP2 11q13
APPLICATION
Distal spinal muscular atrophy 1 (DSMA1), SMARD1, dHMN6
MIX
P059-B1
VERSION
Vs. 03
DATE
04-04-2014
REGION
PRKRA; THAP1; TOR1A; ATP1A3
APPLICATION
Dystonia
MIX
P059-B2
VERSION
Vs. B2-01
DATE
12-07-2018
REGION
PRKRA; THAP1; TOR1A; ATP1A3
APPLICATION
Dystonia